At Averto Medical, our mission to transform gastrointestinal healthcare is powered by the support of esteemed investors who share our vision for innovative, patient-centric solutions. Their commitment enables us to advance our groundbreaking technologies and improve patient outcomes worldwide.
A leading healthcare-focused investment firm, Cormorant Asset Management has been instrumental in supporting innovative biotechnology and medical technology companies. Their strategic guidance and financial backing are pivotal in advancing our clinical-stage developments.
With a rich history of fostering healthcare innovation, Venrock Healthcare Capital Partners brings deep industry expertise and a track record of nurturing successful ventures. Their investment underscores confidence in our mission and potential.
Specializing in life sciences investments, LifeSci Venture Partners provides valuable insights and resources that drive the growth and development of pioneering medical technologies. Their support accelerates our journey toward transforming patient care.
As a dedicated supporter of innovative healthcare solutions, CVF’s investment facilitates our efforts to bring cutting-edge gastrointestinal treatments to market, enhancing the quality of life for patients globally.
